Wellbridge Rehabilitation Program Inpatient

Wellbridge Rehabilitation Program Inpatient

Services:
Testing
• Drug or alcohol urine screening
• TB screening
• Drug and alcohol oral fluid testing
• Testing for Hepatitis C (HCV)
• HIV testing
• Breathalyzer or blood alcohol testing
• Metabolic syndrome monitoring
• Testing for Hepatitis B (HBV)
• STD testing

Medical Services

• Hepatitis B (HBV) vaccination
• Hepatitis A (HAV) vaccination

License/Certification/Accreditation

• The Joint Commission
• Drug Enforcement Agency (DEA)
• State department of health
• State Substance use treatment agency

Assessment/Pre-treatment

• Screening for substance use
• Outreach to persons in the community
• Complete medical history/physical exam
• Comprehensive substance use assessment
• Screening for mental disorders
• Screening for tobacco use

Treatment Approaches

• 12-step facilitation
• Brief intervention
• Relapse prevention
• Cognitive behavioral therapy
• Trauma-related counseling
• Contingency management/motivational incentives
• Telemedicine/telehealth therapy
• Anger management
• Substance use disorder counseling
• Motivational interviewing

Type of Opioid Treatment

• Prescribes naltrexone
• Buprenorphine maintenance
• Relapse prevention with naltrexone
• Maintenance service with medically supervised withdrawal after stabilization
• Prescribes buprenorphine

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Residential/24-hour residential
• Short-term residential

Special Programs/Groups Offered

• Clients who have experienced trauma
• Veterans
• Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
• Adult men
• Adult women

Opioid Medications used in Treatment

• Naltrexone used in Treatment
• Buprenorphine used in Treatment

Facility Smoking Policy

• Smoking permitted in designated area

Facility Operation (e.g., Private, Public)

• Private for-profit organization

Age Groups Accepted

• Young Adults
• Adults

Pharmacotherapies

• Medications for HIV treatment
• Lofexidine
• Clonidine
• Medications for pre-exposure to prophylaxis
• Disulfiram
• Acamprosate (Campral®)
• Naltrexone (oral)
• Nicotine replacement
• Medication for mental disorders
• Medications for Hepatitis C treatment
• Buprenorphine with naloxone
• Non-nicotine smoking/tobacco cessation
• Buprenorphine (extended-release, injectable)
• Naltrexone (extended-release, injectable)
• Buprenorphine without naloxone

Type of Care

• Substance use treatment

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder

External Source of Medications Used for Alcohol Use Disorder Treatment

• Other contracted prescribing entity

Ancillary Services

• Suicide prevention services
• Case management service
• Transportation assistance
• Integrated primary care services

Education and Counseling Services

• Substance use disorder education
• Individual counseling
• Family counseling
• Health education services other than HIV/AIDS or hepatitis
• Group counseling
• Smoking/vaping/tobacco cessation counseling
• Hepatitis education, counseling, or support
• Vocational training or educational support (for example, high school coursework, GED preparation, etc.)
• HIV or AIDS education, counseling, or support

Transitional Services

• Naloxone and overdose education
• Aftercare/continuing care
• Outcome follow-up after discharge
• Discharge Planning

Gender Accepted

• Female
• Male

Recovery Support Services

• Mentoring/peer support
• Housing services
• Self-help groups

Payment/Insurance/Funding Accepted

• Cash or self-payment
• Private health insurance

Facility Vaping Policy

• Vaping not permitted